Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
15. Januar 2025 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the...
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
02. Januar 2025 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
30. Dezember 2024 08:00 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
20. November 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
19. November 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
07. November 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek has introduced the world’s first Enhanced Small Particle (ESP™) Detection Sorter, which opens the door to scientific discoveries.
Cytek Biosciences Reports Third Quarter 2024 Financial Results
05. November 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Participate in Upcoming Investor Conferences
30. Oktober 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
29. Oktober 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third...
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
18. September 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.